Some IV fluids are in short supply due to higher-than-expected demand and manufacturing issues. But why do IV fluids contain different chemicals? And why can’t they be interchanged when one runs low?
The next step in HIV prevention — long-acting injectable pre-exposure prophylaxis (PrEP) — is not yet available in Canada, a year after its approval in the U.S.
While pills are more practical than injections or infusions, digestion in the stomach prevents many drugs from being taken orally. Better drug design could change this.
In the development of new drugs, taking something from nature and modifying it has been a successful tactic employed by medicinal chemists for years. Now, with the help of nanotechnology, researchers are…
The history of science is full of episodes when a seemingly ludicrous theory is ridiculed, but then slowly gathers evidence and support to move from the fringes to the heart of the scientific consensus…
Development of new drugs for treatment of disease is an expensive, time-consuming and labour-intensive effort for both pharmaceutical companies and academics. For the past 15 years, “cost per approval…
While scientists develop new drugs to treat a multitude of conditions, nanotechnology is pushing the boundaries of how we deliver them to patients - targeting delivery to cancer cells and giving a drug…
Awareness during general anaesthesia is very uncommon, but when it occurs it’s distressing for patients and their carers. Our understanding of this phenomenon has grown over the past decade but we’re still…
Associate Professor, Public Health & Social Policy; Special Advisor Health Research, Office of the Vice-President Research and Innovation, University of Victoria